ICD-10-PCS 2027 procedure code
3E09705Introduction of Other Antineoplastic into Nose, Via Natural or Artificial Opening
Short description: Introduction of Other Antineoplastic into Nose, Via Opening
Code unchanged since ICD-10-PCS took effect on October 1, 2015. Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data
About 3E09705
3E09705 is the ICD-10-PCS code for a introduction procedure on the nose using a via natural or artificial opening approach with antineoplastic (qualifier: other antineoplastic). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.
In plain terms, this corresponds to injection or infusion of cancer chemotherapeutic substance, the ICD-9-CM procedure title it maps to (99.25).
For a different body part, codes include 3E0B705 (ear), 3E0C705 (eye), 3E0D705 (mouth and pharynx), 3E0E705 (products of conception), 3E0F705 (respiratory tract), 3E0G705 (upper GI) and 9 more.
The same procedure with a different approach is coded 3E09305 (percutaneous) and 3E09X05 (external).
It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.
It has been valid since ICD-10-PCS took effect on October 1, 2015.
What each character means
- 1. Section
- 3Administration
- 2. Body System
- EPhysiological Systems and Anatomical Regions
- 3. Operation
- 0Introduction
Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
- 4. Body System / Region
- 9Nose
- 5. Approach
- 7Via Natural or Artificial Opening
Entry of instrumentation through a natural or artificial external opening to reach the site of the procedure
- 6. Substance
- 0Antineoplastic
Includes: Amivantamab Monoclonal Antibody; Lurbinectedin; RYBREVANT (tm) (Amivantamab Monoclonal Antibody); ZEPZELCA(tm) (Lurbinectedin)
- 7. Qualifier
- 5Other Antineoplastic
Other versions of this procedure
Different body system / region
Different approach
Different qualifier
ICD-9-CM equivalent
Converter →- 99.25Injection or infusion of cancer chemotherapeutic substanceapproximate
From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.
Code history
- 2016
- 2017
- 2018
- 2019
- 2020
- 2021
- 2022
- 2023
- 2024
- 2025
- 2026
- 2027
- FY2016 (effective 10/1/2015): Added (first year of ICD-10-CM)
- No changes since FY2016.
Common questions about 3E09705
Is 3E09705 a valid ICD-10-PCS code for 2027?
- Yes. 3E09705 is valid for inpatient procedures from October 1, 2026 through September 30, 2027.
What is the ICD-9 procedure code for 3E09705?
- The CMS GEMs map 3E09705 to ICD-9-CM 99.25 (Injection or infusion of cancer chemotherapeutic substance).